Clinical Trial Update: Evaluate the Safety and Efficacy of CAR-T in the Treatment of Pancreatic Cancer. [EARLY_Phase 1]

View source ↗

Summary

An early-phase (Phase 1) study is evaluating the safety and efficacy of CAR-T cell therapy in pancreatic cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• CAR-T cell therapy

Snippet

Sponsor: First Affiliated Hospital of Harbin Medical University | Conditions: Pancreatic Cancer, CAR | EARLY_Phase 1 | Status: UNKNOWN